Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

31 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Innovative Approaches to Monitor Central Line Associated Bloodstream Infections (CLABSIs) Bundle Efficacy in Intensive Care Unit (ICU): Role of Device Standardized Infection Rate (dSIR) and Standardized Utilization Ratio (SUR)-An Italian Experience.
Boni S, Sartini M, Del Puente F, Adriano G, Blasi Vacca E, Bobbio N, Carbone A, Feasi M, Grasso V, Lattuada M, Nelli M, Oliva M, Parisini A, Prinapori R, Santarsiero MC, Tigano S, Cristina ML, Pontali E. Boni S, et al. Among authors: prinapori r. J Clin Med. 2024 Jan 11;13(2):396. doi: 10.3390/jcm13020396. J Clin Med. 2024. PMID: 38256530 Free PMC article.
The Clinical Efficacy of Multidose Oritavancin: A Systematic Review.
Baiardi G, Cameran Caviglia M, Piras F, Sacco F, Prinapori R, Cristina ML, Mattioli F, Sartini M, Pontali E. Baiardi G, et al. Among authors: prinapori r. Antibiotics (Basel). 2023 Sep 29;12(10):1498. doi: 10.3390/antibiotics12101498. Antibiotics (Basel). 2023. PMID: 37887199 Free PMC article. Review.
Impact of the COVID-19 Pandemic on Epidemiology of Antibiotic Resistance in an Intensive Care Unit (ICU): The Experience of a North-West Italian Center.
Parisini A, Boni S, Vacca EB, Bobbio N, Puente FD, Feasi M, Prinapori R, Lattuada M, Sartini M, Cristina ML, Usiglio D, Pontali E. Parisini A, et al. Among authors: prinapori r. Antibiotics (Basel). 2023 Aug 3;12(8):1278. doi: 10.3390/antibiotics12081278. Antibiotics (Basel). 2023. PMID: 37627698 Free PMC article.
Down Syndrome and COVID-19: not always a poor prognosis.
Parisini A, Boni S, Vacca EB, Del Puente F, Feasi M, Bobbio N, Prinapori R, Bolla C, Castellaneta M, Pontali E, Chichino G. Parisini A, et al. Among authors: prinapori r. Int J Tuberc Lung Dis. 2022 Jul 1;26(7):691-693. doi: 10.5588/ijtld.22.0192. Int J Tuberc Lung Dis. 2022. PMID: 35768929 No abstract available.
Atazanavir/ritonavir monotherapy: 96 week efficacy, safety and bone mineral density from the MODAt randomized trial.
Galli L, Spagnuolo V, Bigoloni A, D'Arminio Monforte A, Montella F, Antinori A, Di Biagio A, Rusconi S, Guaraldi G, Di Giambenedetto S, Borderi M, Gibellini D, Caramatti G, Lazzarin A, Castagna A; MODAt Study Group. Galli L, et al. J Antimicrob Chemother. 2016 Jun;71(6):1637-42. doi: 10.1093/jac/dkw031. Epub 2016 Mar 5. J Antimicrob Chemother. 2016. PMID: 26945711 Clinical Trial.
Discontinuation of Initial Antiretroviral Therapy in Clinical Practice: Moving Toward Individualized Therapy.
Di Biagio A, Cozzi-Lepri A, Prinapori R, Angarano G, Gori A, Quirino T, De Luca A, Costantini A, Mussini C, Rizzardini G, Castagna A, Antinori A, dʼArminio Monforte A; ICONA Foundation Study Group. Di Biagio A, et al. Among authors: prinapori r. J Acquir Immune Defic Syndr. 2016 Mar 1;71(3):263-71. doi: 10.1097/QAI.0000000000000849. J Acquir Immune Defic Syndr. 2016. PMID: 26871881 Free PMC article.
Genetic polymorphisms of IL28b gene as predictors of response to dual therapy in genotypes 1 and 4-HCV and HIV/HCV-infected patients.
Sticchi L, Di Biagio A, Sartini M, Rappazzo E, Nicolini LA, Cenderello G, Valle C, Azzola E, Grasso A, De Leo P, Boldrini A, Setti M, Prinapori R, Lorusso C, Bruzzone B, Icardi G; Ligurian HIV Network. Sticchi L, et al. Among authors: prinapori r. New Microbiol. 2015 Oct;38(4):499-509. Epub 2015 Oct 20. New Microbiol. 2015. PMID: 26485009 Free article.
May some HCV genotype 1 patients still benefit from dual therapy? The role of very early HCV kinetics.
Tontodonati M, Cento V, Polilli E, Colabattista C, Cascella R, Sciotti M, Di Giammartino D, Trave F, Di Maio VC, Monarca R, Di Candilo F, Prinapori R, Rastrelli E, Vecchiet J, Ceccherini-Silberstein F, Manzoli L, Giardina E, Perno CF, Parruti G. Tontodonati M, et al. Among authors: prinapori r. New Microbiol. 2015 Oct;38(4):491-7. Epub 2015 Oct 20. New Microbiol. 2015. PMID: 26485008 Free article. Clinical Trial.
31 results